Lebrikizumab Improves Itch, Skin Pain, and the Interference of Itch on Sleep in Adult and Adolescent Patients With Moderate-to-Severe Atopic Dermatitis and Skin of Color: 16-Week Results From the ADmirable Study
Document Type
Conference Proceeding
Publication Date
9-2025
Publication Title
Journal of the American Academy of Dermatology
Volume
93
Issue
3 Suppl
First Page
AB240
Last Page
AB240
Recommended Citation
Alexis A, Moiin A, Waibel J, Wallace P, Cohen D, Laquer V, et al. Lebrikizumab improves itch, skin pain, and the interference of itch on sleep in adult and adolescent patients with moderate-to-severe atopic dermatitis and skin of color: 16-week results from the ADmirable study. J Am Acad Dermatol. 2025 Sep;93(3 Suppl):AB240. doi:10.1016/j.jaad.2025.05.954
DOI
10.1016/j.jaad.2025.05.954
COinS
Comments
American Academy of Dermatology Annual Meeting, March 7-11, 2025, Orlando, FL